Duterte honors wounded, slain cops in CamSur ambush

admin   •   October 24, 2018   •   3663

President Rodrigo Roa Duterte commiserates with the relatives of one of the slain police officers during his visit at the Camarines Sur Provincial Police Office in Naga City on October 23, 2018. SIMEON CELI JR./PRESIDENTIAL PHOT

President Duterte went to Camarines Sur on Tuesday (October 23) where he visited the three policemen who were wounded in the ambush against the convoy of Food and Drug Administration (FDA) Director General Nela Charade Puno in Brgy. Napolidad, Lupi, Camarines Sur last October 18.

The President bestowed the Order of Lapu-Lapu with rank of Kampilan to the three injured cops.

The Kampilan is awarded to government personnel and private individuals who were seriously wounded while carrying out activities related to the President’s advocacy.

Duterte also personally sent condolences to the families of the three other cops who died in the incident, namely, SPO1 Percival Rafael Jr. PO3 Carlito Navaroza Jr. and PO1 Ralph Jason Vida.

He visited the wake of PO1 Vida in Camarines Sur Provincial Police Office and awarded him the Order of Lapu-Lapu with the rank of Kalasag.

Kalasag is given to officials, government personnel and private individuals who lost their lives as a direct result of their participation in tasks pursuant to a campaign or advocacy of the President.

Duterte was joined by FDA Director General Puno whom the wounded police personnel were escorting the day of the incident.

“Maraming maraming salamat sa lahat ng mga nagligtas ng buhay ng Team FDA. Sa mga pulis na nasaktan at mga pulis na namatay, nakakagalit. Si Presidente po ay siguradong hindi papayagan na ganito lang ang mangyari,” said Puno.

President Duterte did not provide any statement to the media, however, Philippine Army 9TH Infantry Battalion Division commanding general MGen. Jesus Manangquil said that Duterte has instructed the Philippine Army and Philippine National Police to intensify the localized peace talks with the New People’s Army, who are responsible for the ambush.

“Nanawagan pa rin ulit kami sa mga nandirito na gumagala sa bundok na mag-usap, mapag-usapan through localized dialogue o peace initiative. Lalong lalo na napakaganda ng iminumungkahi ng ating gobyerno with the package na may pabahay na worth 450,000 na pabahay sa mga mag-susurender na NPA,” said the commanding general. — Yssa Jalmasco (with reports from Allan Manansala)

Duterte orders FDA to deal with illegal sale, distribution of ivermectin

Robie de Guzman   •   April 21, 2021

MANILA, Philippines – President Rodrigo Duterte has directed the Food and Drug Administration (FDA) to take the lead in dealing with illegal traders of anti-parasitic drug ivermectin amid push to use this to treat COVID-19, Malacañang said Wednesday.

“To ensure the safety and welfare of the public and at the same time avoid any unnecessary conflicts, the Food and Drug Administration (FDA) has been directed to take the lead in determining the course of action against the illegal trading/dispensing of Ivermectin,” Presidential Spokesperson Harry Roque said in a statement.

“The Philippine National Police (PNP) cannot arbitrarily determine on their own which drug/s should not be on the market. All operations to apprehend or seize goods must be done in coordination with the FDA,” he added.

Roque, however, clarified that the FDA is only ordered to stop the sale or trade of ivermectin for veterinary use that has been repackaged as human grade, including those that have no been determined by competent authorities as safe to be used in humans.

“Having said this, we advise the public to seek the advice of medical practitioners before taking medicines and/or supplements,” he said.

“The President is closely monitoring the developments concerning ivermectin here and abroad. He has even directed the Presidential Management Staff (PMS) to give him weekly updates on ivermectin studies and FDA-related clearance,” he added.

The FDA earlier granted two hospitals compassionate special permit for ivermectin.

The agency, however, reiterated that a compassionate special permit only allows experimental or unregistered drugs for limited off-label use but this is not an agency’s endorsement of its safety and efficacy.

The agency also emphasized that a compassionate use permit is different from certificate of product registration for the drug, which allows manufacturers to commercially sell the anti-parasitic drug for human use.

The FDA likewise stressed that only the hospital that has secured a permit for ivermectin’s compassionate use for humans will be allowed to import the drug through a licensed importer. Doctors who will use ivermectin to treat COVID-19 patients are required to report to the FDA on a monthly basis.

The FDA also said that distribution and promotion of ivermectin as a COVID-19 treatment remains prohibited in the country.

Ivermectin is registered in the country for veterinary use to prevent heartworm disease and treat internal and external parasites in certain species.

Ivermectin products registered for human use in the country were in topical formulations under prescription use only.

FDA open to probe into alleged delays in EUA, CPR issuances to local drug manufacturers

Marje Pelayo   •   April 21, 2021

MANILA, Philippines — The Food and Drug Administration (FDA) welcomes the intention of the members of the House of Representatives (HOR) to investigate the process on the issuance of permits for drugs specifically the ones that show potential in combatting coronavirus disease (COVID-19).

During the Laging Handa briefing on Tuesday (April 20) FDA Director-General Eric Domingo stated that the agency has a set of standards on issuing approval on applications for Certificate of Product Registration (CPR) and Emergency Use Authorization (EUA).

“Mayroon naman tayong set ng policies at mga standard na sinusunod bago mag-approve po ng isang gamot kasama na ang safety, quality, and evidence on efficacy,” Domingo said.

Domingo said the investigation will help the FDA explain the measures it applies in expediting the country’s access to medicines, diagnostic kits, and other medical needs.

This,  after House Speaker Lord Allan Velasco and Deputy Speaker Bernadette Herrera-Dy filed House Resolution (HR) 1711 that calls on the Committee on Good Government and Public Accountability to look into the policies and guidelines for the registration, utilization, [manufacturing], distribution, and sale of drug products “which appear to be detrimental to public interest”.

Earlier, Velasco also urged the FDA to speed up the process of acquiring permits for local drug manufacturers after the government opened opportunities for the local pharmaceutical industry to boost the country’s response against COVID-19 in addressing the need for vaccines and medicines crisis.

During the briefing, Deputy Speaker Dy pointed out that there seems to be a problem with the process.

“Nakita natin na parang arbitrary kung paano nila pinapakinggan ang WHO or ‘yung iba mabilis ang approval, ‘yung iba matagal,” she said.

“Noong nakausap ko ang mga local pharmaceutical companies natin, they can make the tocilizumab, the remdesivir, pero it seems na nahihirapan silang magpa-register dito mismo sa ating bansa,” she added.

“Marami naman tayo mga foreign clinical trials na pwede nating gamiting basis. Iba kase yung available na siya sa market. Tandaan mo pag sinabi mong compassionate special permit these are for those na malubha na sa ospital. Papaano yung pang prophylactic niya? Paano yung pang prevention niya? Yun yung gusto nating patingnan sa FDA. Baka pwede nilang tingnan sa portion na ito and to make it available,” Dy further said.

For the part of the FDA, Domingo said any investigation would give the agency an avenue to explain their side on the matter.

“We welcome this para pa-explain natin sa ating mga mambabatas kung ano ang ating mga proseso at saka kung ano na ang nagawa natin sa FDA simula ng pandemic,” he said.

Ilang bahagi ng Bicol region binaha at walang kuryente dahil sa epekto ni ‘Bising’

Robie de Guzman   •   April 19, 2021

Baha na sa ilang panig ng Camarines Sur dahil sa walang tigil na pag-ulan bunsod ng bagyong Bising.

Kabilang sa mga binaha ang Himagtocon Lagonoy Spillway kaya hindi ito ngayon madaanan ng lahat ng uri ng sasakyan.

Malakas na ulan rin ang nararanasan ngayon sa Bicol region kaya nagpatupad na ng forced at pre-emptive evacuation sa landslide at flood-prone areas ang mga lokal na pamahalaan.

Sa tala ng Office of the Civil Defense Region 5, aabots sa 27,211 pamilya ang pansamantalang nanunuluyan sa iba’t ibang evacuation centers sa rehiyon.

Paalala naman ng Department of Health sa mga lokal na opisyal na magtalaga ng safety officers na magsasagawa ng clinical at exposure assessment sa lahat ng mga nasa evacuation center upang maiwasan ang pagkalat ng COVID-19 at iba pang uri ng sakit.

Sa Camarines Norte, nawalan ng supply ng kuryente ang ilang lugar dahil sa malalakas na hangin at natumbang mga puno.

Agad namang naalis ang mga punong nakahambalang sa mga kalsada kaya’t maaari pa itong daanan ng mga sasakyan.

May napaulat ding 959 na mga pasaherong naipit sa iba’t ibang pantalan sa Bicol matapos suspindihin ang biyahe ng mga barko.

Hindi rin pinayagang dumaan sa Maharlika Highway sa bayan ng Pilar, Sorsogon ang 87 truck upang maiwasan ang pagdami ng mga truck sa Matnog port.

Sa ngayon ay patuloy pang inaalam ng pamahalaan ng panlalawigan ang pinsala ang bagyong Bising sa rehiyon. – RRD (mula sa ulat ni Correspondent Bryan Baldaraje)

REACH US

The Philippine Broadcast Hub

UNTV, 915 Barangay Philam,

EDSA, Quezon City M.M. 1104

(+632) 8396-8688 (Tel)

info@untv-newsandrescue.com (General inquiries)

ABOUT UNTV

UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.